Suzhou SmartNuclide Biopharmaceutical Secures $13.8 Million in Series C+ Funding to Advance Radiopharmaceutical Pipeline
Suzhou SmartNuclide Biopharmaceutical Co., Ltd, a leading developer of radiopharmaceuticals in China, has announced the...
Finance
Arnatar Therapeutics Secures $50 Million in Series A Funding to Expand into China
US-based biotechnology company Arnatar Therapeutics has successfully closed a $50 million Series A financing round,...
Applied Protein Technology Secures Series C Financing to Accelerate Multi-Omics Innovation
Shanghai-based Applied Protein Technology (APTBIO), a pioneer in life science technology services driven by mass...
ETERN Therapeutics Secures Funding to Advance LLPS Platform and Clinical Trials for Anti-Tumor Drugs
ETERN Therapeutics, a Shanghai-based developer of small-molecule anti-tumor drugs, has announced the commencement of a...
Shanghai Unveils Massive Investment Projects and Funds to Boost High-Tech Industries
Shanghai has unleashed a flurry of policy-backed project signings and initiatives, marking a significant boost...
Beijing’s Changping District and State-owned Capital Firm Launch RMB 20 Billion Healthcare Fund
The Changping district of Beijing municipality has reached an agreement with Beijing State-owned Capital Operation...
Merck Expands Global Footprint with Largest M Lab Collaboration Center in Shanghai
Merck KGaA (ETR: MRK), a leading German technology company, has announced the completion of the...
Sanofi Projects EUR 13 Billion in Dupixent Sales for 2024 Despite Q1 Challenges
Sanofi (NASDAQ: SNY), a leading French pharmaceutical company, has released its guidance for the first...
Golden Leaf Med Tec Secures Series D Funding to Advance Hypertension and Diabetes Treatments
Shanghai Golden Leaf Med Tec Co., Ltd, a specialist in interventional treatments based in China,...
Astra Biotech Raises Tens of Millions in Pre-Series B Funding to Expand Diagnostic Capabilities
Astra Biotech, a developer of single molecule immunodiagnostic technology based in Suzhou, has reportedly raised...
Horimed Secures Tens of Millions in Financing to Advance OCT Imaging Technologies
Horimed, a Tianjin-based manufacturer of OCT imaging equipment, has reportedly raised “tens of millions” of...
Beijing Varnotech Biopharm Secures RMB 600 Million in Series B Funding for Vaccine Development
Beijing Varnotech Biopharm Ltd, a China-based specialist in human vaccines, has successfully raised RMB 600...
PoreSpect Secures Tens of Millions in Angel Funding Led by Forcefield Ventures
PoreSpect, a Guangdong-based manufacturer of devices and consumables, has reportedly secured “tens of millions” of...
Novo Nordisk Invests RMB 4 Billion to Expand Sterile Manufacturing in Tianjin
Novo Nordisk (NYSE: NVO), a Denmark-based leader in diabetes care, has announced a substantial investment...
Shanghai Winpu Technology and Silver Mars Merge Under YinKe Holding to Accelerate Healthcare Innovation
Shanghai Winpu Technology Co., Ltd., a specialist in medical-grade polymer materials based in China, has...
Microenergy Medical Technology Secures Pre-Series A Funding to Advance Medical Devices
Microenergy Medical Technology Co., Ltd, a Hangzhou-based manufacturer of active intervention medical devices, has reportedly...
Fosun Pharma Launches RMB 5 Billion Fund to Boost Biopharmaceutical Investments in Shenzhen
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196, HKG: 2196) has unveiled plans to establish...
Simnova Secures RMB 200 Million in Series A+ Funding to Advance CAR Therapy Pipeline
Simnova, a Shenzhen-based developer of chimeric antigen receptor (CAR) adoptive cell therapies, has successfully raised...
Merck’s 2023 Annual Report: A Mixed Bag Amid Global Challenges
Merck KGaA (ETR: MRK), a leading German chemical, reported a 5.6% decline in its global...
Zylox-Tonbridge Medical Technology Secures Licensing Deal with Avinger to Boost Device Portfolio
Zylox-Tonbridge Medical Technology (HKG: 2190), a China-based developer of nerve and peripheral vascular interventional devices,...